Capstone Investment Advisors
TWST icon

Capstone Investment Advisors’s Twist Bioscience TWST Stock Holding History

Capstone Investment Advisors’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-8,727
Closed -$321K – 2075
2025
Q2 		$321K Buy
+8,727
New +$302K ﹤0.01% 1357
2024
Q3 		– Sell
-4,299
Closed -$212K – 2210
2024
Q2 		$212K Buy
+4,299
New +$175K ﹤0.01% 1752

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

Capstone Investment Advisors's TWST Position: Q3 2025 in Review

Capstone Investment Advisors sold out of Twist Bioscience (TWST) in Q3 2025, closing a stake of 8,727 shares — an estimated $321K sold.

Capstone Investment Advisors first reported a position in TWST in Q2 2024 and held it in 2 quarters. The position peaked at $321K in Q2 2025. 238 funds tracked by Wall St. Rank hold TWST as of Q3 2025.

  • Capstone Investment Advisors reported no remaining Twist Bioscience position as of Q3 2025 after selling out during the quarter.
  • Capstone Investment Advisors sold 8,727 Twist Bioscience shares in Q3 2025, an estimated $321K.
  • Capstone Investment Advisors first reported a position in Twist Bioscience in Q2 2024 and held it in 2 quarters.
  • Capstone Investment Advisors's Twist Bioscience position peaked at $321K in Q2 2025.
  • 238 funds tracked by Wall St. Rank held Twist Bioscience as of Q3 2025.

Based on Capstone Investment Advisors's 13F filing for Q3 2025, filed 14 Nov 2025.